A Shared Decision Making Training for Inpatients With Schizophrenia
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Technische Universität München.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Technische Universität München
Collaborator:
The German-Israeli Foundation for Scientific Research and Development
Information provided by:
Technische Universität München
ClinicalTrials.gov Identifier:
NCT00885716
First received: April 20, 2009
Last updated: April 7, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients suffering from schizophrenia who attend the communication skills program engage more deeply in therapeutic reasoning and treatment decisions. This results in stronger preferences to participate, greater perceived involvement and better long term adherence compared to patients who do not attend the training.
| Condition | Intervention |
|---|---|
|
Schizophrenia Schizoaffective Disorder |
Behavioral: patient training in shared decision making Behavioral: cognitive training |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Shared Decision Making: Ein Kommunikationstraining für Patienten Mit Schizophrenie |
Resource links provided by NLM:
Further study details as provided by Technische Universität München:
Primary Outcome Measures:
- Decision Self Efficacy [ Time Frame: post intervention ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Adherence to medication [ Time Frame: 6 months post intervention ] [ Designated as safety issue: No ]
- Participation preferences [ Time Frame: post intervention ] [ Designated as safety issue: No ]
- Treatment satisfaction [ Time Frame: post intervention ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 80 |
| Study Start Date: | May 2009 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: communication skills training
group training in shared decision making.
|
Behavioral: patient training in shared decision making |
|
Active Comparator: cognitive training
standard group training of cognitive skills (Konzentrationstraining)
|
Behavioral: cognitive training |
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Male and female inpatients with a diagnosis of schizophrenia/schizoaffective disorder according to ICD 10
- between 18 and 60 years of age are eligible for the study
- informed consent
- inpatients
Exclusion Criteria:
- poor German language skills
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00885716
Contacts
| Contact: Johannes Hamann, MD | +49894140 ext 4282 | j.hamann@lrz.tum.de |
Locations
| Germany | |
| Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München | Recruiting |
| München, Germany | |
| Sub-Investigator: Werner Kissling, MD | |
| Principal Investigator: Johannes Hamann, MD | |
Sponsors and Collaborators
Technische Universität München
The German-Israeli Foundation for Scientific Research and Development
More Information
No publications provided by Technische Universität München
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | PD Dr. Johannes Hamann, Technische universität München |
| ClinicalTrials.gov Identifier: | NCT00885716 History of Changes |
| Other Study ID Numbers: | GIF2168-1764.1 |
| Study First Received: | April 20, 2009 |
| Last Updated: | April 7, 2010 |
| Health Authority: | Germany: Federal Ministry of Education and Research |
Additional relevant MeSH terms:
|
Psychotic Disorders Schizophrenia Schizophrenia and Disorders with Psychotic Features Mental Disorders |
ClinicalTrials.gov processed this record on May 23, 2013